JAMA Network
About The Study: The efficacy and safety observed in this randomized clinical trial suggest that low-dose atropine may provide a treatment option for childhood myopia progression.
Authors: Karla Zadnik, O.D., Ph.D., of the Ohio State University College of Optometry in Columbus, is the corresponding author.
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(doi:10.1001/jamaophthalmol.2023.2097)
/Public Release. This material from the originating organization/author(s) might be of the point-in-time nature, and edited for clarity, style and length. Mirage.News does not take institutional positions or sides, and all views, positions, and conclusions expressed herein are solely those of the author(s).View in full here.
